指南与共识系统性红斑狼疮

系统性红斑狼疮医师整体评估国际标准化共识:PISCOS研究

Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study.
指南 / 共识 · Lancet Rheumatol · 2022-05-04

PISCOS研究通过三轮德尔菲共识流程,由79名国际SLE专家对41条关于医师整体评估(PGA)的陈述进行评分,最终就27条陈述达成共识并形成14条推荐。专家小组同意PGA应采用0-3视觉模拟量表评估SLE患者过去一个月的疾病活动度,仅由有经验的医师评分,且每次访视最好由同一评估者评分。

要点

  • PGA应采用0-3视觉模拟量表评估SLE患者过去一个月的疾病活动度。
  • PGA评估整体疾病活动度,考虑活动性表现的严重度和临床实验室结果,但排除器官损伤、血清学及与疾病活动无关的主观发现。
  • PGA量表从「无疾病活动」(0)到「最严重疾病活动」(3),以1和2为内部标记,将疾病活动度分为轻度(≥0.5至1)、中度(>1且≤2)和重度(>2至3)。

核心结论

  • PISCOS研究就PGA在SLE中的应用、PGA量表设计、PGA评分的实用考虑以及PGA值与疾病活动度水平的关系达成共识,共27条陈述归为14条推荐。
  • PISCOS结果将有助于提高常规临床实践中PGA评分的同质性和可靠性、缓解和低疾病活动度的定义以及未来的SLE试验。

研究设计与样本

  • PISCOS研究旨在获得基于证据和专家的SLE疾病活动度PGA评分标准化共识。
  • 由79名SLE专家组成的国际小组参与了三轮德尔菲共识流程,对41条与PGA相关的陈述使用0(强烈不同意)至10(强烈同意)的数字评定量表进行评分。
  • 同意度达到75%或以上的陈述被选中,并由专家小组进一步验证。

主要发现

  • 共识在27条陈述上达成,归为14条推荐,涉及PGA在SLE中的使用、PGA量表设计、PGA评分的实用考虑以及PGA值与疾病活动度水平的关系。
  • 专家小组同意PGA应由0-3视觉模拟量表组成,用于测量SLE患者过去一个月的疾病活动度。
  • PGA旨在评估整体疾病活动度,考虑活动性表现的严重度和临床实验室结果,但排除器官损伤、血清学以及与疾病活动无关的主观发现。
  • PGA量表范围从「无疾病活动」(0)到「最严重疾病活动」(3),并以1和2作为内部标记将疾病活动度分为轻度(≥0.5至1)、中度(>1且≤2)和重度(>2至3)。
  • 只有有经验的医师才能进行PGA评分,且每次访视最好由同一评估者评分。

关键数值与推荐

  • PGA采用0-3视觉模拟量表,评估SLE患者过去一个月的疾病活动度。
  • PGA评估整体疾病活动度,包含活动性表现的严重度和临床实验室结果,排除器官损伤、血清学和与疾病活动无关的主观发现。
  • 疾病活动度分级:轻度为≥0.5至1,中度为>1且≤2,重度为>2至3。
  • PGA仅由有经验的医师评分,每次访视最好由同一评估者评分。

临床怎么用

  • PISCOS推荐PGA使用0-3视觉模拟量表评估SLE患者过去一个月的疾病活动度。
  • PISCOS推荐PGA评估整体疾病活动度,考虑活动性表现的严重度和临床实验室结果,但排除器官损伤、血清学及与疾病活动无关的主观发现。
  • PISCOS推荐PGA仅由有经验的医师评分,且每次访视最好由同一评估者评分。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus (PISCOS) study aimed to obtain an evidence-based and expert-based consensus standardisation of the Physician Global Assessment (PGA) scoring of disease activity in systemic lupus erythematosus (SLE). An international panel of 79 SLE experts participated in a three-round Delphi consensus process, in which 41 statements related to the PGA in SLE were rated, using a 0 (strongly disagree) to 10 (strongly agree) numerical rating scale. Statements with agreement of 75% or greater were selected and further validated by the expert panel. Consensus was reached on 27 statements, grouped in 14 recommendations, for the use of the PGA in SLE, design of the PGA scale, practical considerations for PGA scoring, and the relationship between PGA values and levels of disease activity. Among these recommendations, the expert panel agreed that the PGA should consist of a 0-3 visual analogue scale for measuring disease activity in patients with SLE in the preceding month. The PGA is intended to rate the overall disease activity, taking into account the severity of active manifestations and clinical laboratory results, but excluding organ damage, serology, and subjective findings unrelated to disease activity. The PGA scale ranges from "no disease activity" (0) to the "most severe disease activity" (3) and incorporates the values 1 and 2 as inner markers to categorise disease activity as mild (≥0·5 to 1), moderate (>1 and ≤2) and severe (>2 to 3). Only experienced physicians can rate the PGA, and it should be preferably scored by the same rater at each visit. The PISCOS results will allow for increased homogeneity and reliability of PGA ratings in routine clinical practice, definitions of remission and low disease activity, and future SLE trials.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Piga M, Chessa E, Morand EF, et al. Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study. Lancet Rheumatol. 2022. PMID: 38293958. doi:10.1016/S2665-9913(22)00107-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。